Fig. 4From: Selective antagonism of cJun for cancer therapyOverview of the potential interactions of a cJun antagonist. This highlights some potential competitive interactions which the antagonist must overcome in order to selectively bind to the cJun target; outcompeting both homodimerisation and interactions with off target componentsBack to article page